Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter‐observational study
T. Acciavatti; Matteo Lupi; Rita Santacroce; Andrea Aguglia; Luigi Attademo; Laura Bandini; Paola Ciambrone; Giulia Lisi · 2017 · Human Psychopharmacology Clinical and Experimental
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract (excerpt)
OBJECTIVE: Comorbidities between psychiatric diseases and use of traditional substances of abuse are common. Nevertheless, there are few data regarding the use of novel psychoactive substances (NPS) among psychiatric patients. Aim of this…
Excerpt shown for reference under fair use — read the full paper at the publisher.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
Solvent‐Free Ball‐Milling Biginelli Reaction by Subcomponent Synthesis
Negative / Null Result ReportAcute liver failure
Negative / Null Result ReportA Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients
Negative / Null Result ReportMenthol concentration in topical cold gel does not have significant effect on skin cooling
Negative / Null Result ReportDevelopment of a digital twin of a tablet that mimics a real solid dosage form: Differences in the dissolution profile in conventional mini-USP II and a biorelevant colon model
Negative / Null Result ReportInnovative dual-functional hybrid cationic PEGylated proniosomes as a smart nano-platform for Boosted vaginal delivery: multi-level in-vitro, ex-vivo, microbiological, and in-vivo studies
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: OpenAlex · DOI 10.1002/hup.2578